TW201919664A - 性功能障礙之處理與性生活品質之改良 - Google Patents

性功能障礙之處理與性生活品質之改良 Download PDF

Info

Publication number
TW201919664A
TW201919664A TW107120931A TW107120931A TW201919664A TW 201919664 A TW201919664 A TW 201919664A TW 107120931 A TW107120931 A TW 107120931A TW 107120931 A TW107120931 A TW 107120931A TW 201919664 A TW201919664 A TW 201919664A
Authority
TW
Taiwan
Prior art keywords
mesenchymal stem
sexual
stem cell
stem cells
patient
Prior art date
Application number
TW107120931A
Other languages
English (en)
Chinese (zh)
Inventor
約書亞 Ｍ 哈爾
達西 Ｌ 迪芙迪
Original Assignee
美商生命科學公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商生命科學公司 filed Critical 美商生命科學公司
Publication of TW201919664A publication Critical patent/TW201919664A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW107120931A 2017-06-19 2018-06-19 性功能障礙之處理與性生活品質之改良 TW201919664A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762521765P 2017-06-19 2017-06-19
US62/521,765 2017-06-19

Publications (1)

Publication Number Publication Date
TW201919664A true TW201919664A (zh) 2019-06-01

Family

ID=62952383

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107120931A TW201919664A (zh) 2017-06-19 2018-06-19 性功能障礙之處理與性生活品質之改良

Country Status (12)

Country Link
US (1) US12496316B2 (enExample)
EP (1) EP3641793A1 (enExample)
JP (1) JP7343123B2 (enExample)
KR (1) KR20200017516A (enExample)
CN (1) CN111107858A (enExample)
AU (1) AU2018288653A1 (enExample)
CA (1) CA3067354A1 (enExample)
IL (1) IL271395A (enExample)
SG (1) SG11201912209UA (enExample)
TW (1) TW201919664A (enExample)
WO (1) WO2018236680A1 (enExample)
ZA (1) ZA201908451B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021340971A1 (en) 2020-09-08 2023-03-30 Longeveron, Inc. Treatment of Alzheimer's disease with allogeneic mesenchymal stem cells
EP4376950A1 (en) 2021-07-26 2024-06-05 Longeveron Inc. Use of mesenchymal stem cells in treatment of juvenile hypoplastic left heart syndrome
CA3226181A1 (en) 2021-09-10 2023-03-16 Longeveron Inc. Treatment of aging frailty comprising administering bone marriw derived mesenchymal stem cells
KR102762783B1 (ko) * 2022-01-21 2025-02-05 고현서 심리 프로파일에 따른 행동 습관 제공 방법, 서버, 저장 매체 및 디바이스
WO2025137077A1 (en) 2023-12-19 2025-06-26 Longeveron, Inc. Improved brain architecture and biomarkers in alzheimer's disease with mesenchymal stem cells
WO2025199451A2 (en) 2024-03-21 2025-09-25 Longeveron Inc. Mmp-14 potency assay for mesenchymal stem cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
WO2007149548A2 (en) * 2006-06-22 2007-12-27 Medistem Laboratories, Inc. Treatment of erectile dysfunction by stem cell therapy
WO2010021996A1 (en) * 2008-08-18 2010-02-25 Junta De Beneficiencia De Guayaquil Treatment of injuries to the central nervous system
EP2486930B1 (en) 2009-10-06 2016-03-23 National University Corporation Nagoya University Cell preparation containing adipose tissue derived mesenchymal stem cells for use in the treatment of a condition of no urge to urinate
WO2013173694A2 (en) * 2012-05-18 2013-11-21 The Cooper Health System A method of restoring endothelial/smooth muscle architecture and cell signaling pathways to sexual organs
EA202190962A2 (ru) 2014-05-30 2022-02-28 Оникс Терапьютикс, Инк. Уровни экспрессии иммуноглобулинов в качестве биологического маркера для реакции на ингибитор протеасом
CN105055450A (zh) 2015-02-13 2015-11-18 中国福利会国际和平妇幼保健院 人宫内膜干细胞在制备治疗卵巢早衰的药物中的应用

Also Published As

Publication number Publication date
US12496316B2 (en) 2025-12-16
CN111107858A (zh) 2020-05-05
SG11201912209UA (en) 2020-01-30
AU2018288653A1 (en) 2020-01-16
JP2020524179A (ja) 2020-08-13
WO2018236680A1 (en) 2018-12-27
ZA201908451B (en) 2021-05-26
EP3641793A1 (en) 2020-04-29
JP7343123B2 (ja) 2023-09-12
US20200129558A1 (en) 2020-04-30
CA3067354A1 (en) 2018-12-27
IL271395A (en) 2020-01-30
KR20200017516A (ko) 2020-02-18

Similar Documents

Publication Publication Date Title
TW201919664A (zh) 性功能障礙之處理與性生活品質之改良
EP2744892B1 (en) Therapeutics using adipose cells and cell secretions
JP6622189B2 (ja) 疼痛及び／又は線維症の調節において脂肪組織由来細胞を使用する方法
Öksüz et al. The effect of subcutaneous mesenchymal stem cell injection on statis zone and apoptosis in an experimental burn model
He et al. Transplantation KCNMA 1 modified bone marrow‐mesenchymal stem cell therapy for diabetes mellitus‐induced erectile dysfunction
US20240009233A1 (en) Macrophage Cell Therapy to Treat Orthopedic Injury
JP2022095884A (ja) 単離ミトコンドリアを含む関節リウマチの予防または治療のための医薬組成物
Alhefnawy et al. Autologous mesenchymal stem cell therapy for diabetic men with erectile dysfunction. Is it promising? A pilot study
Protogerou et al. Stem cell therapy for erectile dysfunction: preliminary results from a single-center pilot study in Greece
AU2015252071B2 (en) Systemic, allogenic stem cell therapies for treatment of diseases in animals
AU2013204930C1 (en) Therapeutics using multiple injections of cells
US9724394B2 (en) Pharmaceutical composition for preventing or treating osteoporosis which comprises neuropeptide Y as active ingredient
HK40015513A (en) Therapeutics using adipose cells and cell secretions
Martini et al. Therapeutic applications of stem cells obtained from peripheral blood in tendons, ligaments and skin injuries
AU2019203058A1 (en) Stem cells and secretions for treatment of inflammatory conditions
HK1226601B (en) Methods of using adipose tissue-derived cells in the treatment of raynaud’s phenomenon associated with scleroderma
AU2014200367A1 (en) Therapeutics using multiple injections of cells